Latest News

MeTLAND Early Access Program

Diagram of DNA sequencing process showing a Nexus device, DNA double helix, magnifying glass with 'Me', and laboratory equipment.

Early Access Program for MeTLAND is now live!

Be among the first to test MeTLAND

on your own samples!

More information

Our achievements

  • November 2025

    NEXUS awarded the Vinnova Innovative Startups Grant!

  • October 2025

    Akshaya joined the R&D team as a Research Assistant, strengthening our assay development and validation efforts.

  • September 2025

    Brian represented NEXUS at the XCELLS Conference on Epigenetics and Health in Brussels, sharing our progress and expanding partnerships.

  • August 2025

    Brian joined NEXUS as Business Development Strategist, helping drive customer outreach and early-access program growth.

  • June 2025

    NEXUS was awarded an ERC Proof of Concept grant in collaboration with the Castelo-Branco Lab at Karolinska Institutet and the Bartosovic Lab at Stockholm University.

  • April 2025

    Our CEO Mukund and COO Jana presented NEXUS at the KI Innovations Investor Day 2025, showcasing our platform and future roadmap.

  • March 2025

    Our CEO and Co-Founder Mukund, was selected as one of ten recipients of the FUHS x SEB Innovation Scholarship for promising startup founders.

  • February 2025

    NEXUS won the Dragons’ Den pitch competition during the KI Innovations DRIVE Program, placing first among all competing startups.

  • January 2025

    NEXUS received a Seal of Excellence from the European Research Council for the MeTLAND project.